Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

2.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harnessing Immunogenic PANoptosis With Iridium(III) Biradical Photosensitizers for Melanoma Photoimmunotherapy.

Angewandte Chemie (International ed. in English)·2026
Same author

Encapsulation of a ruthenium-platinum photosensitizer into nanofibrous membranes for antibacterial photodynamic therapy.

Journal of materials chemistry. B·2026
Same author

Correction to "Three in One: <i>In Vitro</i> and <i>In Vivo</i> Evaluation of Anticancer Activity of a Theranostic Agent that Combines Magnetic Resonance Imaging, Optical Bioimaging, and Photodynamic Therapy Capabilities".

ACS applied bio materials·2026
Same author

Correction to "Photodecaging of a Mitochondria-Localized Iridium(III) Endoperoxide Complex for Two-Photon Photoactivated Therapy under Hypoxia".

Journal of the American Chemical Society·2026
Same author

Exploiting Metal-to-Metal Electron Transfer in a Ru(II) Polypyridine-Deferasirox Conjugate for Hypoxic Photodynamic Therapy.

Journal of the American Chemical Society·2026
Same author

Metal complexes in medicine: structural scaffolds <i>vs.</i> functional centres.

Chemical science·2026

Related Experiment Video

Updated: Sep 15, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K

Gallium(III) Complex Induces Immunogenic Cell Death Hallmarks for Chemoimmunotherapy.

Zisis Papadopoulos1, Yassin Antar1,2, Irma-Sofie Dieter2

  • 1Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780 Bochum, Germany.

Journal of Medicinal Chemistry
|July 18, 2025
PubMed
Summary

A novel gallium (Ga(III)) complex effectively kills various cancer cells by inducing immunogenic cell death (ICD). This compound shows promise for combined chemotherapy and immunotherapy against metastatic cancers.

More Related Videos

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.6K
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.5K

Related Experiment Videos

Last Updated: Sep 15, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.6K
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.5K

Area of Science:

  • Inorganic Chemistry
  • Cancer Research
  • Immunology

Background:

  • Tumor metastases are a primary cause of cancer mortality.
  • Chemotherapeutic agents inducing immunogenic cell death (ICD) offer potential for metastatic cancer treatment.
  • Gallium (Ga(III)) complexes are explored for their therapeutic properties.

Purpose of the Study:

  • To synthesize and biologically evaluate a novel Ga(III) complex with Schiff bases for cancer therapy.
  • To investigate the compound's potential for combined chemotherapy and immunotherapy.
  • To assess the compound's efficacy in inducing immunogenic cell death.

Main Methods:

  • Chemical synthesis of the Ga(III) complex: [Ga((E)-1-((quinolin-8-ylimino)methyl)naphthalen-2-olato)2][Cl].
  • In vitro cytotoxicity assays against human breast, pancreatic, and cervical cancer cell lines, and human fibroblasts.
  • Mechanistic studies to identify apoptosis and ICD hallmarks (calreticulin exposure, eIF2α phosphorylation, HMGB1 release, ATP release).
  • In vitro assessment using multicellular tumor spheroids of cervical cancer cell lines.

Main Results:

  • The Ga(III) complex demonstrated broad cytotoxicity against tested cancer cell lines.
  • The compound induced key hallmarks of ICD, including calreticulin translocation, eIF2α phosphorylation, HMGB1 migration, and ATP release.
  • Successful eradication of cervical cancer multicellular tumor spheroids was achieved at micromolar concentrations.
  • The study reports one of the few Ga(III) complexes capable of inducing ICD.

Conclusions:

  • The novel Ga(III) complex is a potent inducer of ICD.
  • This compound holds significant potential for developing new therapeutic strategies against metastatic cancers.
  • Further research into Ga(III) complexes for combined chemo-immunotherapy is warranted.